Search research articles
Contact Us
Filters
Showing results (51-60 of 297) with videos related to
Page
of 30
Sort By:
Current Rheumatology Reports
|
December 30, 2015
Recent Developments in the Classification, Evaluation, Pathophysiology, and Management of Scleroderma Renal Crisis
Cybele Ghossein, John Varga, Andrew Z Fenves
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 17, 2005
Coexisting systemic lupus erythematosus and sickle cell disease: a diagnostic and therapeutic challenge
Nader A Khalidi, Harpinder Ajmani, John Varga
Current Rheumatology Reports
|
September 26, 2020
Adipocytic Progenitor Cells Give Rise to Pathogenic Myofibroblasts: Adipocyte-to-Mesenchymal Transition and Its Emerging Role in Fibrosis in Multiple Organs
Roberta Goncalves Marangoni, Benjamin Korman, John Varga
Arthritis and Rheumatism
|
July 9, 2003
Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts
Yasuji Mori, Shu-Jen Chen, John Varga
Current Opinion in Rheumatology
|
September 8, 2021
The dynamic organelle primary cilia: emerging roles in organ fibrosis
Dibyendu Bhattacharyya, Maria E Teves, John Varga
Current Rheumatology Reports
|
March 14, 2002
Scleroderma-like cutaneous syndromes
Yasuji Mori, Veli-Matti Kahari, John Varga
Trends in Molecular Medicine
|
June 18, 2024
Senescence and tissue fibrosis: opportunities for therapeutic targeting
Steven O'Reilly, Pei-Suen Tsou, John Varga
Seminars in Cell & Developmental Biology
|
April 11, 2022
Tenascin-C in fibrosis in multiple organs: Translational implications
Swati Bhattacharyya, Kim S Midwood, John Varga
Nature Reviews. Rheumatology
|
September 4, 2021
Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential
Pei-Suen Tsou, John Varga, Steven O'Reilly
Current Rheumatology Reports
|
July 17, 2009
Tyrosine kinase inhibitors in systemic sclerosis: the case for imatinib
Flavia V Castelino, Swati Bhattacharyya, John Varga
Page
of 30
Search research articles
Search
Showing results (51-60 of 297) with videos related to
Sort By:
Page
of 30
Current Rheumatology Reports
|
December 30, 2015
Recent Developments in the Classification, Evaluation, Pathophysiology, and Management of Scleroderma Renal Crisis
Cybele Ghossein, John Varga, Andrew Z Fenves
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 17, 2005
Coexisting systemic lupus erythematosus and sickle cell disease: a diagnostic and therapeutic challenge
Nader A Khalidi, Harpinder Ajmani, John Varga
Current Rheumatology Reports
|
September 26, 2020
Adipocytic Progenitor Cells Give Rise to Pathogenic Myofibroblasts: Adipocyte-to-Mesenchymal Transition and Its Emerging Role in Fibrosis in Multiple Organs
Roberta Goncalves Marangoni, Benjamin Korman, John Varga
Arthritis and Rheumatism
|
July 9, 2003
Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts
Yasuji Mori, Shu-Jen Chen, John Varga
Current Opinion in Rheumatology
|
September 8, 2021
The dynamic organelle primary cilia: emerging roles in organ fibrosis
Dibyendu Bhattacharyya, Maria E Teves, John Varga
Current Rheumatology Reports
|
March 14, 2002
Scleroderma-like cutaneous syndromes
Yasuji Mori, Veli-Matti Kahari, John Varga
Trends in Molecular Medicine
|
June 18, 2024
Senescence and tissue fibrosis: opportunities for therapeutic targeting
Steven O'Reilly, Pei-Suen Tsou, John Varga
Seminars in Cell & Developmental Biology
|
April 11, 2022
Tenascin-C in fibrosis in multiple organs: Translational implications
Swati Bhattacharyya, Kim S Midwood, John Varga
Nature Reviews. Rheumatology
|
September 4, 2021
Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential
Pei-Suen Tsou, John Varga, Steven O'Reilly
Current Rheumatology Reports
|
July 17, 2009
Tyrosine kinase inhibitors in systemic sclerosis: the case for imatinib
Flavia V Castelino, Swati Bhattacharyya, John Varga
Page
of 30